| # | Drug | Count |
|---|---|---|
| 0 | ARIPIPRAZOLE | 38 |
| 1 | ARIPIPRAZOLE ORAL | 28 |
| 2 | ARIPIPRAZOLE ORALLY DISINTEGRATING | 28 |
| 3 | OLANZAPINE | 28 |
| 4 | RISPERIDONE | 28 |
| 5 | CLOZAPINE | 27 |
| 6 | ACETAMINOPHEN | 21 |
| 7 | THIAMINE HYDROCHLORIDE | 21 |
| 8 | CITALOPRAM | 19 |
| 9 | LORAZEPAM | 19 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | AMISULPRIDE | 16 | 0.0026 |
| 1 | CARIPRAZINE | 11 | 0.0011 |
| 2 | INFLIXIMAB-DYYB | 3 | 0.0009 |
| 3 | AMOXICILLIN AND CLAVULANATE POTASSIUM | 3 | 0.0007 |
| 4 | HALOPERIDOL LACTATE | 16 | 0.0006 |
| 5 | PHENELZINE SULFATE | 1 | 0.0006 |
| 6 | SENNOSIDES A AND B | 1 | 0.0006 |
| 7 | OLANZAPINE AND SAMIDORPHAN L-MALATE | 1 | 0.0006 |
| 8 | VALPROATE SODIUM | 12 | 0.0006 |
| 9 | CEFADROXIL | 1 | 0.0005 |
| # | Drug class | Count |
|---|---|---|
| 0 | Atypical Antipsychotic [EPC] | 107 |
| 1 | Benzodiazepine [EPC] | 56 |
| 2 | Nonsteroidal Anti-inflammatory Drug [EPC] | 26 |
| 3 | Dopamine-2 Receptor Antagonist [EPC] | 16 |
| 4 | Mood Stabilizer [EPC] | 16 |
| 5 | Serotonin Reuptake Inhibitor [EPC] | 16 |
| 6 | Typical Antipsychotic [EPC] | 16 |
| 7 | Angiotensin Converting Enzyme Inhibitor [EPC] | 14 |
| 8 | Anti-epileptic Agent [EPC] | 14 |
| 9 | Osmotic Laxative [EPC] | 14 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Dopamine-2 Receptor Antagonist [EPC] | 16 | 0.0021 |
| 1 | Typical Antipsychotic [EPC] | 16 | 0.0006 |
| 2 | beta Lactamase Inhibitor [EPC] | 2 | 0.0004 |
| 3 | Atypical Antipsychotic [EPC] | 107 | 0.0002 |
| 4 | Thiazide-like Diuretic [EPC] | 9 | 0.0002 |
| 5 | Ergot Derivative [EPC] | 1 | 0.0002 |
| 6 | Serotonin Reuptake Inhibitor [EPC] | 16 | 0.0002 |
| 7 | Provitamin D2 Compound [EPC] | 5 | 0.0002 |
| 8 | Alkaloid [EPC] | 3 | 0.0001 |
| 9 | Angiotensin Converting Enzyme Inhibitor [EPC] | 14 | 0.0001 |